Back | Next |
home / stock / mynz / mynz message board
Subject | By | Source | When |
---|---|---|---|
$MYNZ where is the squeeze? | BlazingStocks | investorshub | 04/24/2023 4:25:12 PM |
Time for this to show some returns | pumpnass | investorshub | 04/24/2023 1:01:22 PM |
$MYNZ Do we have a winner?Turn around time? | budfoxfun | investorshub | 04/24/2023 12:06:23 PM |
$MYNZ Good news recently, we should start to see this one move | BlazingStocks | investorshub | 04/24/2023 11:54:15 AM |
$MYNZ and the shorts continue | budfoxfun | investorshub | 04/24/2023 11:06:07 AM |
What do you make of this? | BlazingStocks | investorshub | 04/24/2023 10:48:11 AM |
Price gaining | Mrogers23 | investorshub | 04/24/2023 10:00:18 AM |
$MYNZ bears are running | budfoxfun | investorshub | 04/24/2023 7:37:01 AM |
$MYNZ The now last trade up | budfoxfun | investorshub | 04/24/2023 7:30:23 AM |
$MYNZ Have a look at this | cuggegrosse | investorshub | 04/24/2023 4:40:56 AM |
where is the squeeze? | BlazingStocks | investorshub | 04/24/2023 1:01:02 AM |
$MYNZ Price now | BlazingStocks | investorshub | 04/24/2023 12:12:20 AM |
$MYNZ Lets go go go go... Up up and away we go. | budfoxfun | investorshub | 04/23/2023 9:18:24 PM |
$MYNZ The now | BlazingStocks | investorshub | 04/23/2023 8:19:48 PM |
Price trading | budfoxfun | investorshub | 04/23/2023 7:11:57 PM |
$MYNZ MomentumIts gaining up | esi23 | investorshub | 04/23/2023 3:31:21 PM |
$MYNZ Thoughts on where this is headed? | BlazingStocks | investorshub | 04/23/2023 10:49:10 AM |
Found an interesting article | BlazingStocks | investorshub | 04/23/2023 10:39:25 AM |
$MYNZ just the news we needed | BlazingStocks | investorshub | 04/23/2023 9:35:17 AM |
Time for this to show some returns | pumpnass | investorshub | 04/23/2023 9:34:54 AM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer sc...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this new configuration demonstrates sens...
BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...